Lucigen | LGC代理,ClearColi BL21(DE3) Electrocompetent Cells,部分现货

发表于由

ClearColi BL21(DE3) Electrocompetent Cells

Eliminate endotoxin at the source with this unique engineered E. coli strain for low-endotoxin protein expression.

Product Details

Each ClearColi® BL21(DE3) Electrocompetent Cell Kit contains: ClearColi BL21(DE3) Electrocompetent Cells in DUO packaging (2 transformations per tube), Expression Recovery Medium (lactose minus), pUC19 Positive Control Plasmid, and complete protocols.

Expression Recovery Medium (lactose minus) is also available separately.

Key features

  • Eliminate endotoxin at the source
  • Genetically modified LPS does not trigger endotoxic response in human cells
  • Ideal for mammalian cell immunogenicity testing, toxicity assays, and therapeutic protein drug discovery
  • Useful for membrane and lipid binding protein production
  • Protein expression similar to BL21(DE3) cells without requiring downstream endotoxin removal
  • Reduce false positives in cytokine assays, improve confidence in your results

Select a Size

Please select a Size

Lucigen | LGC, Biosearch Technologies主要开发各类用于基因克隆的试剂盒及相关产品，包括：CloneSmart®平端克隆试剂盒、BigEasy®线性克隆系统、pEZSeq™平端克隆试剂盒、聚合酶及E.cloni®感受态细胞及蛋白表达系统等。

Lucigen公司凭借其独到的产品技术，过硬的产品质量，良好的产品服务赢得了全球广大用户的信赖。此外，Lucigen还是全球科学家青睐的Epicentre品牌产品的供应商。在2018年，Lucigen被LGC收购，从而加强了其在基因组市场的试剂供应。Lucigen的产品和服务已经覆盖了临床诊断、药物开发、合成生物学和基因编辑等多个领域。更多产品信息欢迎访问Lucigen | LGC, Biosearch Technologies官网。